AU5129398A - Particulate compositions - Google Patents

Particulate compositions

Info

Publication number
AU5129398A
AU5129398A AU51293/98A AU5129398A AU5129398A AU 5129398 A AU5129398 A AU 5129398A AU 51293/98 A AU51293/98 A AU 51293/98A AU 5129398 A AU5129398 A AU 5129398A AU 5129398 A AU5129398 A AU 5129398A
Authority
AU
Australia
Prior art keywords
particulate compositions
particulate
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51293/98A
Inventor
Kathrin Bjerknes
Kari Dyvik
Anne Kjersti Fahlvik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed Imaging AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging AS filed Critical Nycomed Imaging AS
Publication of AU5129398A publication Critical patent/AU5129398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles
AU51293/98A 1996-11-29 1997-11-28 Particulate compositions Abandoned AU5129398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9624918.0A GB9624918D0 (en) 1996-11-29 1996-11-29 Particulate components
GB9624918 1996-11-29
PCT/GB1997/003283 WO1998023297A2 (en) 1996-11-29 1997-11-28 Particulate compositions

Publications (1)

Publication Number Publication Date
AU5129398A true AU5129398A (en) 1998-06-22

Family

ID=10803721

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51293/98A Abandoned AU5129398A (en) 1996-11-29 1997-11-28 Particulate compositions

Country Status (5)

Country Link
EP (1) EP1009445A2 (en)
JP (1) JP2001504837A (en)
AU (1) AU5129398A (en)
GB (1) GB9624918D0 (en)
WO (1) WO1998023297A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20004795D0 (en) 2000-09-26 2000-09-26 Nycomed Imaging As Peptide-based compounds
EP2029184B1 (en) * 2006-05-26 2011-02-23 Baxter International Inc. Injectable fibrin composition for bone augmentation
CA2793277C (en) 2010-03-23 2018-09-04 Ge Healthcare As Preparation of stabilised x-ray diagnostic composition
EP2606912A1 (en) * 2011-12-23 2013-06-26 Central Medical Service Co., Ltd. Contrast medium composition with contrast enhancement effect by comprising highly concentrated agent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0414806B1 (en) * 1988-05-20 1994-07-20 The Liposome Company, Inc. High ratio active agent:lipid complex
IS1685B (en) * 1990-12-11 1998-02-24 Bracco International B.V. Method of making liposomes that are endowed with enhanced ability to absorb and contain foreign matter
ZA952485B (en) * 1994-03-28 1995-12-15 Nycomed Imaging As Liposomes
CN1148336A (en) * 1994-03-28 1997-04-23 第一制药株式会社 Liposome with increased retention volume
DE19606326A1 (en) * 1995-02-09 1996-08-22 Schering Ag Liposomal diagnostic formulation, esp. for blood pool imaging
EP0759785B1 (en) * 1995-02-24 2001-10-31 Bracco Research S.A. Liposome suspensions as blood pool imaging contrast agents

Also Published As

Publication number Publication date
WO1998023297A3 (en) 1998-07-16
WO1998023297A2 (en) 1998-06-04
EP1009445A2 (en) 2000-06-21
GB9624918D0 (en) 1997-01-15
JP2001504837A (en) 2001-04-10

Similar Documents

Publication Publication Date Title
AU3803697A (en) Polyester compositions
AU4239697A (en) Cleaning compositions
AU4027195A (en) Water-in-oil-in-water compositions
AU5259398A (en) Hopper
AU4762797A (en) Pharmaceutical compositions
AU2967597A (en) Pharmaceutical compositions
AU2925797A (en) Cleaning compositions
AU3469899A (en) Particulate compositions
AU2906997A (en) Microencapsulated compositions
AU3308195A (en) Antihypertriglyceridemic composition
AU2972597A (en) Compositions and uses thereof
AU5157898A (en) Hnf3delta compositions
AU3777897A (en) Pharmaceutical compositions
AU5335798A (en) Stomatic composition
AU9742098A (en) Autophobic hairspray compositions
AU8747498A (en) Food-preservative composition
AU5575398A (en) Hairdye compositions
AU2373597A (en) Particulate materials
AU3352397A (en) Additive composition
AU5274298A (en) Cleaning compositions
AU8121998A (en) Composition
AU2815997A (en) Cleaning compositions
AU1098499A (en) Emulsifier-lipid composition
AU1129697A (en) Modified polyalkadiene-containing compositions
AU4326197A (en) Pharmaceutical compositions